×
About 3,313 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  1,563 results

Direct oral anticoagulants for therapeutic anticoagulation in postoperative pulmonary e...
https://doi.org/10.1016/j.jocn.2020.09.059
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia; Dubinski D, Won SY et. al.

Nov 23rd, 2020 - Acute postoperative pulmonary embolism (PE) is a dreaded complication with severe mortality rates. Brain tumor patients are at the highest risk for postoperative PE. The juxtaposition of low-molecular-weight heparin (LMWH), vitamin K antagonists (...

Device related thrombus after left atrial appendage closure: State of the art.
https://doi.org/10.1111/pace.14122
Pacing and Clinical Electrophysiology : PACE; Yu J, Bai Y et. al.

Nov 9th, 2020 - Atrial fibrillation (AF), the most common arrhythmia, is a major cause of stroke and systemic embolism. Patients with AF are at higher risk of stroke with the left atrial appendage (LAA) being the most common site for thrombus formation. Although ...

A Country-Based Comparison of Atrial Fibrillation Patient Preferences for Oral Anticoag...
https://doi.org/10.1097/FJC.0000000000000936
Journal of Cardiovascular Pharmacology; Henry M, Wosnitza M et. al.

Nov 9th, 2020 - The aim of this study was to examine atrial fibrillation (AF) patients' preferences regarding oral anticoagulation (OAC) characteristics and to investigate differences across five different countries. A multi-center discrete choice experiment (DCE...

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirr...
https://doi.org/10.1007/s12325-020-01550-4
Advances in Therapy; Wang L, Guo X et. al.

Nov 6th, 2020 - Benefit and risk of anticoagulation in cirrhotic patients with portal vein thrombosis (PVT) remain controversial, especially in those with asymptomatic PVT and in non-liver transplant candidates. Furthermore, the predictors of portal vein recanali...

Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Th...
https://doi.org/10.1007/s10620-020-06695-4
Digestive Diseases and Sciences; Naymagon L, Tremblay D et. al.

Nov 5th, 2020 - The role of anticoagulation (AC) in the management of cirrhotic patients with portal vein thrombosis (PVT) remains unclear. We conducted a retrospective study of cirrhotic patients diagnosed with PVT from 1/1/2000 through 2/1/2019, comparing those...

see more →

Guidelines  7 results

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.040267
Circulation Schnabel RB,et al

Nov 25th, 2019 - Cardiac thromboembolism attributed to atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes. Stroke may be the first manifestation of previously undetected AF. Given the efficacy of oral anticoagulants in preventing AF-re...

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report
https://journal.chestnet.org/article/S0012-3692(18)32244-X/abstract
Lip, G.,et al.

Nov 27th, 2018 - The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical be.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: opt...
http://www.bloodadvances.org/content/2/22/3257
Witt, D.

Nov 26th, 2018 - Background: Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support.

Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline...
http://www.learnicu.org/SiteCollectionDocuments/VTE-Prophylaxis-Neuro-Guideline.pdf
Paul Nyquist

Dec 7th, 2015 - The risk of death from venous thromboembolism (VTE) is high in intensive care unit patients with neurological diagnoses. This is due to an increased risk of venous stasis secondary to paralysis as well as an increased prevalence of underlying path.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  1,649 results

Direct oral anticoagulants for therapeutic anticoagulation in postoperative pulmonary e...
https://doi.org/10.1016/j.jocn.2020.09.059
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia; Dubinski D, Won SY et. al.

Nov 23rd, 2020 - Acute postoperative pulmonary embolism (PE) is a dreaded complication with severe mortality rates. Brain tumor patients are at the highest risk for postoperative PE. The juxtaposition of low-molecular-weight heparin (LMWH), vitamin K antagonists (...

Device related thrombus after left atrial appendage closure: State of the art.
https://doi.org/10.1111/pace.14122
Pacing and Clinical Electrophysiology : PACE; Yu J, Bai Y et. al.

Nov 9th, 2020 - Atrial fibrillation (AF), the most common arrhythmia, is a major cause of stroke and systemic embolism. Patients with AF are at higher risk of stroke with the left atrial appendage (LAA) being the most common site for thrombus formation. Although ...

A Country-Based Comparison of Atrial Fibrillation Patient Preferences for Oral Anticoag...
https://doi.org/10.1097/FJC.0000000000000936
Journal of Cardiovascular Pharmacology; Henry M, Wosnitza M et. al.

Nov 9th, 2020 - The aim of this study was to examine atrial fibrillation (AF) patients' preferences regarding oral anticoagulation (OAC) characteristics and to investigate differences across five different countries. A multi-center discrete choice experiment (DCE...

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirr...
https://doi.org/10.1007/s12325-020-01550-4
Advances in Therapy; Wang L, Guo X et. al.

Nov 6th, 2020 - Benefit and risk of anticoagulation in cirrhotic patients with portal vein thrombosis (PVT) remain controversial, especially in those with asymptomatic PVT and in non-liver transplant candidates. Furthermore, the predictors of portal vein recanali...

Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Th...
https://doi.org/10.1007/s10620-020-06695-4
Digestive Diseases and Sciences; Naymagon L, Tremblay D et. al.

Nov 5th, 2020 - The role of anticoagulation (AC) in the management of cirrhotic patients with portal vein thrombosis (PVT) remains unclear. We conducted a retrospective study of cirrhotic patients diagnosed with PVT from 1/1/2000 through 2/1/2019, comparing those...

see more →

News  93 results

'Low-Risk' Valvular AF in Some May be Risky Enough for Oral Anticoagulation
https://www.staging.medscape.com/viewarticle/937294

Sep 10th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...

'Low-Risk' Valvular AF in Some May be Risky Enough for Oral Anticoagulation
https://www.medscape.com/viewarticle/937294

Sep 10th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...

Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in the Frail, Very Elderly
https://www.staging.medscape.com/viewarticle/936684

Aug 31st, 2020 - An ultra-low dose of direct oral anticoagulant (DOAC) may safely cut the risk for stroke in very elderly patients with atrial fibrillation (AF) whose bleeding risk is considered too high for standard dosages, suggests a randomized trial conducted ...

Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in the Frail, Very Elderly
https://www.medscape.com/viewarticle/936684

Aug 31st, 2020 - An ultra-low dose of direct oral anticoagulant (DOAC) may safely cut the risk for stroke in very elderly patients with atrial fibrillation (AF) whose bleeding risk is considered too high for standard dosages, suggests a randomized trial conducted ...

FDA Approves WATCHMAN FLX for Stroke Reduction by LAA Occlusion
https://www.medscape.com/viewarticle/934375

Jul 21st, 2020 - The US Food and Drug Administration (FDA) has approved Boston Scientific's WATCHMAN FLX transcatheter left atrial appendage (LAA) occluder device as an alternative to oral anticoagulation (OAC) therapy in patients with nonvalvular atrial fibrillat...

see more →